FBLG insider buying and SEC filings, explained
FibroBiologics, Inc. · CIK 1958777
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- FibroBiologics Inc.
Insider activity in the last 12 months
Bought
$120K
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 4, 2026 | Purchase (code P) | Hamid Khoja (Chief Scientific Officer) bought 30,000 shares at $0.3800 ($11K), reported as a purchase (code P). Holdings up 96% to 61,250 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 2–4, 2026 | Purchase (code P) | Pete O'Heeron (CEO and Director) bought 51,500 shares between Mar 2 and Mar 4 at about $0.3805 ($20K), reported as a purchase (code P). Holdings up 1% to 5,958,147 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Purchase (code P) | Jason Davis (CFO) bought 70,000 shares at about $0.4100 ($29K), reported as a purchase (code P). New position of 70,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Purchase (code P) | Ruben A. Garcia (General Counsel) bought 40,000 shares at about $0.3300 ($13K), reported as a purchase (code P). Holdings up 29% to 180,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Dec 11, 2025 | Purchase (code P) | Ruben A. Garcia (General Counsel) bought 140,000 shares at about $0.3400 ($48K), reported as a purchase (code P). New position of 140,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$73K in purchases since Feb 27, 2026 · Purchases traded Feb 27, 2026 to Mar 4, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Ruben A. Garcia (General Counsel) | $13K | Feb 27, 2026 | SEC filing |
| Jason Davis (CFO) | $29K | Mar 2, 2026 | SEC filing |
| Pete O'Heeron (CEO) | $20K | Mar 4, 2026 | SEC filing |
| Hamid Khoja (Chief Scientific Officer) | $11K | Mar 4, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow FBLG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.